Joseph Jacob, MD, outlines key findings on TAR-200 monotherapy from cohort 2 of the SunRISe-1 study.
Joseph M. Jacob, MD, MCR
Advertisement
Articles by Joseph M. Jacob, MD, MCR
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
2026 AUA North Central Section Meeting: Updates in high-risk NMIBC
2
UGN-101 shows durable responses in low-grade upper tract urothelial carcinoma
3
Tamim Niazi, MDCM, reviews darolutamide data from DASL-HiCaP
4
ESMO 2026 On Location - Why pCR is not the whole story in cisplatin-ineligible MIBC
5